Your browser doesn't support javascript.
loading
Omalizumab ameliorates extrarespiratory symptoms in patients with aspirin-exacerbated respiratory disease.
Hayashi, Hiroaki; Fukutomi, Yuma; Mitsui, Chihiro; Kajiwara, Keiichi; Watai, Kentaro; Tomita, Yasuhiro; Kamide, Yosuke; Tsuburai, Takahiro; Sekiya, Kiyoshi; Ishii, Makoto; Hasegawa, Yoshinori; Taniguchi, Masami.
Afiliación
  • Hayashi H; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Fukutomi Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
  • Mitsui C; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
  • Kajiwara K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
  • Watai K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; Center for Immunology and Allergology, Shonan Kamakura General Hospital, Kamakura, Japan.
  • Tomita Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Kamide Y; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
  • Tsuburai T; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; Department of Respiratory Medicine, St Marianna University School of Medicine, Yokohama City Seibu Hospital, Yokohama, Japan.
  • Sekiya K; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan.
  • Ishii M; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Hasegawa Y; Department of Respiratory Medicine, Nagoya University Graduate School of Medicine, Nagoya, Japan; National Hospital Organization of Nagoya Medical Center, Nagoya, Japan.
  • Taniguchi M; Clinical Research Center for Allergy and Rheumatology, National Hospital Organization, Sagamihara National Hospital, Sagamihara, Japan; Center for Immunology and Allergology, Shonan Kamakura General Hospital, Kamakura, Japan. Electronic address: m_taniguchi@shonankamakura.or.jp.
J Allergy Clin Immunol ; 151(6): 1667-1672.e2, 2023 06.
Article en En | MEDLINE | ID: mdl-36967017
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sinusitis / Asma Inducida por Aspirina Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sinusitis / Asma Inducida por Aspirina Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: J Allergy Clin Immunol Año: 2023 Tipo del documento: Article País de afiliación: Japón